<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="8">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05161039</url>
  </required_header>
  <id_info>
    <org_study_id>CSP-0485</org_study_id>
    <nct_id>NCT05161039</nct_id>
  </id_info>
  <brief_title>Serranator Recoil Study</brief_title>
  <official_title>Recoil Feasibility Study for the Treatment of Atherosclerotic Lesions in the Infrapopliteal Arteries Comparing Serration Angioplasty (Serranator® Device) vs. Plain Balloon Angioplasty (POBA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cagent Vascular LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cagent Vascular LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study objective is to assess the ability to define and measure post treatment recoil in&#xD;
      infrapopliteal arteries. Preliminary evidence as to the differences between serration&#xD;
      angioplasty and standard balloon angioplasty as defined by post treatment recoil, lumen gain,&#xD;
      and dissection will be collected.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Multi-center, feasibility study treating up to 20 atherosclerotic lesions in the&#xD;
      infrapopliteal arteries. The study will capture angiographic imaging (pre, during, post, and&#xD;
      post 15 mins) for all lesions, and a subset (up to 10) of IVUS imaging data (pre, post, and&#xD;
      post 15 mins), to compare serration angioplasty vs standard angioplasty and its effects on&#xD;
      vessel recoil and final diameter stenosis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 15, 2021</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">February 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of post treatment recoil</measure>
    <time_frame>15 minutes post procedure</time_frame>
    <description>Obtain preliminary data on post treatment recoil in infrapopliteal arteries utilizing angiographic and IVUS data following serration angioplasty and standard angioplasty.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <condition>Critical Limb Ischemia</condition>
  <arm_group>
    <arm_group_label>Serranator</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>POBA</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Serranator</intervention_name>
    <description>Serranator® PTA Serration Balloon Catheter manufactured by Cagent Vascular</description>
    <arm_group_label>Serranator</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>POBA</intervention_name>
    <description>Plain balloon angioplasty device</description>
    <arm_group_label>POBA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male or female of &gt;18 years old.&#xD;
&#xD;
          2. Women of childbearing potential must have a negative urine pregnancy test within 7&#xD;
             days of index procedure.&#xD;
&#xD;
          3. Subject or subject's legal representative has been informed of the nature of the&#xD;
             study, agrees to participate, and comply, and has signed the consent form.&#xD;
&#xD;
          4. Subject has Rutherford Clinical Category 3, 4, 5, or 6.&#xD;
&#xD;
        Angiographic Inclusion Criteria:&#xD;
&#xD;
          1. Target lesion(s) has stenosis &gt;70% by visual assessment;&#xD;
&#xD;
          2. De-novo, or non-stented re-stenotic lesions;&#xD;
&#xD;
          3. Reference vessel diameter is between 2.5 mm and 3.5 mm, inclusive;&#xD;
&#xD;
          4. Target lesions involve infrapopliteal tibial arteries including pedal;&#xD;
&#xD;
          5. A target lesion may consist of one long or multiple serial lesions that are up to and&#xD;
             including 12 cm in length;&#xD;
&#xD;
          6. If a second lesion is identified in another vessel, the second lesion can also be&#xD;
             treated and if treated will be treated with the alternate treatment.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Evidence of aneurysm or acute thrombus in the target vessel.&#xD;
&#xD;
          2. Subject has an allergy to contrast medium that cannot be pretreated.&#xD;
&#xD;
          3. Subject is pregnant or breastfeeding.&#xD;
&#xD;
        Angiographic Exclusion Criteria:&#xD;
&#xD;
          1. Acute Total Occlusions; evidence of acute thrombus formation by angiography.&#xD;
&#xD;
          2. In-stent restenotic lesions.&#xD;
&#xD;
          3. Inability to cross the lesion with the assigned study device.&#xD;
&#xD;
          4. Treatment of target lesion with atherectomy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Audrey Sahns</last_name>
    <phone>610.688.2006</phone>
    <email>asahns@cagentvascular.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Klinik für Angiologie, Klinikum Hochsauerland GmbH</name>
      <address>
        <city>Arnsberg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Stahlhoff, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 19, 2021</study_first_submitted>
  <study_first_submitted_qc>December 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2021</study_first_posted>
  <last_update_submitted>December 6, 2021</last_update_submitted>
  <last_update_submitted_qc>December 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

